WallStreetZenWallStreetZen

How to Buy Corvus Pharmaceuticals Stock

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies.

Corvus Pharmaceuticals stock last closed at $2.35, up 1.73% from the previous day, and has increased 212.08% in one year. It has overperformed other stocks in the Biotechnology industry by 2.36 percentage points. Corvus Pharmaceuticals stock is currently +287.15% from its 52-week low of $0.61, and -43.91% from its 52-week high of $4.19.

As of Feb 23, 2024, there are 49.04M CRVS shares outstanding. The market capitalization of CRVS is $115.24M. In the last 24 hours, 105,488 CRVS shares were traded.

How to Buy Corvus Pharmaceuticals Stock

Not sure how to invest in Corvus Pharmaceuticals stock? Here's how.
  1. Decide where to buy Corvus Pharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you determine where to buy Corvus Pharmaceuticals stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Pick your method of payment and add your info.
  4. Research Corvus Pharmaceuticals stock: The Corvus Pharmaceuticals ticker symbol is CRVS. Is Corvus Pharmaceuticals stock a good investment? Should you buy shares of CRVS? How do CRVS's underlying business fundamentals look? Do top analysts think Corvus Pharmaceuticals is a good buy? Why has CRVS's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if CRVS is a good stock to buy).
  5. Execute your CRVS purchase: Decide if you will purchase CRVS shares at the current market price or use a limit order to purchase CRVS stock at a particular price.
  6. Keep tabs on your CRVS investment: Create a watchlist to keep tabs on your investment in Corvus Pharmaceuticals stock.

Step 1: Decide where to buy Corvus Pharmaceuticals stock

You will need a brokerage account to access the NASDAQ market and buy CRVS shares.

A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best place to buy stocks. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to world markets: From Tech to Energy, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
  • Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by signing up for an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've selected the best brokerage, it's time to fill out some personal details so you are able to invest in CRVS today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal details to open your new trading account.
  1. Submit your information by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you have finished signing up on one of the best stock trading apps, you need to deposit funds:

Check out this video walkthrough if you need help depositing funds into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Corvus Pharmaceuticals stock

After you have chosen the best place to buy Corvus Pharmaceuticals stock, it's absolutely critical to evaluate their stock before you invest, so you actually wrap your head around the risk and opportunity.

Corvus Pharmaceuticals stock at a glance

CRVS Price
$2.35
1w %
2.62%
1y %
212.08%
5y %
-45.98%
P/E
-3.67x
P/B
2.6x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$30.19M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$115.24M
Next Earnings
Mar 26, 2024
Next Dividend
N/A

Corvus Pharmaceuticals Fundamentals

WallStreetZen was built to help part-time investors do better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on CRVS's stock page.

Is CRVS stock overvalued?

Analysts use many financial metrics, analyses, models, and charts to gauge CRVS's true value.

Using relative valuations measures:

  • CRVS may be undervalued based on its P/B ratio of 2.6x, relative to Biotechnology industry P/B ratio of 6.12x

You can do more valuation analysis on CRVS's stock here.

CRVS Financial Summary

Signs that CRVS is financially healthy:

  • CRVS has $32.17M in cash and short term investments. This is enough to cover its annual cash burn of $26.33M.
  • CRVS has cash burn of 26327000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the CRVS balance sheet.
  • There are more short-term assets than long-term liabilities on the CRVS balance sheet.
  • CRVS has a low debt to equity ratio of 0.17.

Signs that CRVS is not financially healthy:

  • Total CRVS debt is higher than 5 years ago, relative to shareholder equity.

Do Wall Street analysts think it's a good time to buy CRVS stock

Out of 1 sell side analysts who give recommendations on CRVS, the consensus analyst rating on Corvus Pharmaceuticals is a Strong Buy

It's important to note that analyst forecasts are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are forecasting on the Corvus Pharmaceuticals stock forecast page.

CRVS Technicals

SMA10
2.29
SMA20
2.17
SMA50
2
SMA100
1.71
SMA200
2.02
MACD
0.09
MACD Signal
0.08
MACD Histogram
0.01
RSI
62.46
Stochastic %K
59.37
Stochastic %D
57.99
StochRSI %K
79.12
StochRSI %D
77.28

Are CRVS insiders buying or selling the stock?

Over the past 12 months, executives and large shareholders at CRVS have bought more shares than they have sold.

Linda Grais, Director of CRVS, was the latest CRVS insider to buy. They bought $24,500.00 worth of CRVS shares on May 15, 2023.

Research more about who owns CRVS stock here.

Does CRVS stock generate passive income?

No, Corvus Pharmaceuticals doesn't provide an income stream by paying out dividends.

What others are saying about CRVS

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Execute your CRVS purchase

You have two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are mostly fine.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at a specific dollar amount, use a limit order.

Click the Open Trade button and your broker will execute the order.

If you need additional help investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep tabs on your CRVS investment

Now that you own some CRVS stock, you'll want to keep up with your new investment.

Put CRVS on a watchlist to keep track of your CRVS stock.

CRVS Feed

How to Buy Stock in Corvus Pharmaceuticals

To summarize, here are the 6 steps to buy stock in Corvus Pharmaceuticals:

  1. Decide where to buy Corvus Pharmaceuticals stock
  2. Sign up for a brokerage account
  3. Fund your brokerage account
  4. Research Corvus Pharmaceuticals stock
  5. Execute your CRVS purchase
  6. Keep tabs on your CRVS investment

If you require a brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep an eye on your new investment in Corvus Pharmaceuticals, create a watchlist today.

NASDAQ: CRVS
$2.35+0.04 (+1.73%)
Updated Feb 23, 2024
Open eToro Account
NASDAQ: CRVS
$2.35+0.04 (+1.73%)
Updated Feb 23, 2024
Open eToro Account

FAQ

How much does it cost to buy one Corvus Pharmaceuticals share?

As of Feb 23, 2024, it costs $2.35 to buy one share of Corvus Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.426 shares of CRVS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Corvus Pharmaceuticals stock?

According to 1 Wall Street analysts who monitor Corvus Pharmaceuticals, their consensus recommendation is to buy Corvus Pharmaceuticals stock.

What is the best way to buy Corvus Pharmaceuticals stock?

One way to place an order for Corvus Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.